Aquestive Therapeutics, formerly MonoSol Rx Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Aquestive Therapeutics, formerly MonoSol Rx and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 135 Aquestive Therapeutics, formerly MonoSol Rx employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Aquestive Therapeutics, formerly MonoSol Rx has purchased the following applications: GoDaddy for Application Hosting and Computing Services in 2015, Microsoft 365 for Collaboration in 2017, Veeva CRM for CRM in 2021 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Aquestive Therapeutics, formerly MonoSol Rx is running and its propensity to invest more and deepen its relationship with GoDaddy , Microsoft , Veeva Systems or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Aquestive Therapeutics, formerly MonoSol Rx revenues, which have grown to $51.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Aquestive Therapeutics, formerly MonoSol Rx intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.

x